Loading...

Aquestive Therapeutics, Inc.

AQSTNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.15
$-0.05(-1.19%)

Aquestive Therapeutics, Inc. (AQST) Stock Overview

Explore Aquestive Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.2/100

Key Financials

Market Cap412.2M
P/E Ratio-7.38
EPS (TTM)$-0.58
ROE1.07%
Fundamental Analysis

AI Price Forecasts

1 Week$3.08
1 Month$3.27
3 Months$3.80
1 Year Target$5.70

AQST Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aquestive Therapeutics, Inc. (AQST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.38 and a market capitalization of 412.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;